キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/03/18 | 2,372 | 2,423 | 2,369 | 2,396 | -5 | -0.2% | 118,800 |
2021/03/17 | 2,400 | 2,416 | 2,370 | 2,401 | -17 | -0.7% | 87,400 |
2021/03/16 | 2,353 | 2,420 | 2,347 | 2,418 | +54 | +2.3% | 108,400 |
2021/03/15 | 2,291 | 2,364 | 2,290 | 2,364 | +84 | +3.7% | 130,300 |
2021/03/12 | 2,279 | 2,281 | 2,241 | 2,280 | -19 | -0.8% | 116,900 |
2021/03/11 | 2,284 | 2,302 | 2,266 | 2,299 | +23 | +1% | 91,700 |
2021/03/10 | 2,287 | 2,307 | 2,269 | 2,276 | -14 | -0.6% | 135,800 |
2021/03/09 | 2,268 | 2,300 | 2,246 | 2,290 | +59 | +2.6% | 177,600 |
2021/03/08 | 2,249 | 2,252 | 2,221 | 2,231 | +12 | +0.5% | 101,000 |
2021/03/05 | 2,212 | 2,225 | 2,192 | 2,219 | +47 | +2.2% | 112,400 |
2021/03/04 | 2,184 | 2,188 | 2,156 | 2,172 | -20 | -0.9% | 88,600 |
2021/03/03 | 2,200 | 2,200 | 2,175 | 2,192 | +1 | ±0% | 87,100 |
2021/03/02 | 2,195 | 2,198 | 2,171 | 2,191 | -12 | -0.5% | 67,800 |
2021/03/01 | 2,159 | 2,203 | 2,149 | 2,203 | +81 | +3.8% | 74,100 |
2021/02/26 | 2,217 | 2,217 | 2,122 | 2,122 | -92 | -4.2% | 97,000 |
2021/02/25 | 2,263 | 2,263 | 2,212 | 2,214 | -16 | -0.7% | 62,200 |
2021/02/24 | 2,239 | 2,257 | 2,221 | 2,230 | -7 | -0.3% | 115,800 |
2021/02/22 | 2,247 | 2,254 | 2,232 | 2,237 | +8 | +0.4% | 65,600 |
2021/02/19 | 2,245 | 2,249 | 2,212 | 2,229 | -24 | -1.1% | 77,600 |
2021/02/18 | 2,291 | 2,304 | 2,245 | 2,253 | -45 | -2% | 73,700 |
2021/02/17 | 2,296 | 2,314 | 2,287 | 2,298 | +2 | +0.1% | 42,400 |
2021/02/16 | 2,279 | 2,305 | 2,271 | 2,296 | +30 | +1.3% | 53,900 |
2021/02/15 | 2,282 | 2,282 | 2,254 | 2,266 | +12 | +0.5% | 51,400 |
2021/02/12 | 2,293 | 2,293 | 2,248 | 2,254 | -28 | -1.2% | 77,900 |
2021/02/10 | 2,306 | 2,306 | 2,272 | 2,282 | -25 | -1.1% | 38,800 |
2021/02/09 | 2,326 | 2,336 | 2,290 | 2,307 | -44 | -1.9% | 64,200 |
2021/02/08 | 2,312 | 2,355 | 2,299 | 2,351 | +41 | +1.8% | 80,300 |
2021/02/05 | 2,300 | 2,317 | 2,276 | 2,310 | +29 | +1.3% | 80,900 |
2021/02/04 | 2,280 | 2,302 | 2,253 | 2,281 | -3 | -0.1% | 57,800 |
2021/02/03 | 2,283 | 2,295 | 2,262 | 2,284 | -28 | -1.2% | 78,700 |
2021/02/02 | 2,355 | 2,355 | 2,283 | 2,312 | +3 | +0.1% | 124,700 |
2021/02/01 | 2,307 | 2,338 | 2,292 | 2,309 | +4 | +0.2% | 87,600 |
2021/01/29 | 2,287 | 2,339 | 2,281 | 2,305 | +4 | +0.2% | 120,500 |
2021/01/28 | 2,274 | 2,324 | 2,263 | 2,301 | -3 | -0.1% | 120,600 |
2021/01/27 | 2,252 | 2,312 | 2,251 | 2,304 | +64 | +2.9% | 90,600 |
2021/01/26 | 2,234 | 2,240 | 2,218 | 2,240 | +12 | +0.5% | 140,900 |
2021/01/25 | 2,225 | 2,238 | 2,212 | 2,228 | +15 | +0.7% | 95,200 |
2021/01/22 | 2,249 | 2,257 | 2,213 | 2,213 | -61 | -2.7% | 94,000 |
2021/01/21 | 2,268 | 2,308 | 2,268 | 2,274 | +6 | +0.3% | 72,200 |
2021/01/20 | 2,261 | 2,275 | 2,235 | 2,268 | +25 | +1.1% | 50,700 |
2021/01/19 | 2,275 | 2,290 | 2,242 | 2,243 | -48 | -2.1% | 62,800 |
2021/01/18 | 2,290 | 2,302 | 2,274 | 2,291 | -6 | -0.3% | 38,500 |
2021/01/15 | 2,339 | 2,345 | 2,297 | 2,297 | -45 | -1.9% | 78,600 |
2021/01/14 | 2,302 | 2,367 | 2,275 | 2,342 | +74 | +3.3% | 112,000 |
2021/01/13 | 2,300 | 2,306 | 2,249 | 2,268 | -50 | -2.2% | 87,300 |
2021/01/12 | 2,288 | 2,333 | 2,282 | 2,318 | +48 | +2.1% | 97,400 |
2021/01/08 | 2,236 | 2,279 | 2,235 | 2,270 | +49 | +2.2% | 87,000 |
2021/01/07 | 2,237 | 2,253 | 2,221 | 2,221 | +10 | +0.5% | 85,500 |
2021/01/06 | 2,168 | 2,238 | 2,168 | 2,211 | +47 | +2.2% | 99,000 |
2021/01/05 | 2,165 | 2,201 | 2,150 | 2,164 | -1 | ±0% | 81,800 |
1101~
1150
件表示中 / 3783件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 447,000円 | +3.6% | - | 2.68% | 15.06倍 | 0.89倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
日本新薬 | 329,300円 | +3.6% | -15.3% | 3.77% | 9.25倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ペプチド | 173,400円 | +5.0% | +1.5% | 0.00% | 14.84倍 | 4.18倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
サンバイオ | 239,300円 | - | - | 0.00% | - | 110.84倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
科研薬 | 389,900円 | -6.4% | -71.8% | 4.87% | 43.42倍 | 0.97倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム